Id Counterfeit Pharmaceuticals with Portable Raman
Rigaku
| « Previous month | Next month » |
30-Mar-2008
Thermo unveils FT-IR spectrometer
30-Mar-2008 - Thermo Fisher has launched a new spectrometer that incorporates FT-IR technology for improved clarity and detail, aimed at pharmaceutical process scientists and other chemical disciplines.
China watchdog responds to heparin scare; AZ now affected
30-Mar-2008 - China's drug regulatory authority is finally responding to curb its damaged reputation by urging its local authorities to take a more proactive role in stemming what is fast becoming a...
Credit crunch sinks MonoSol IPO
30-Mar-2008 - A planned $60-$70m (€38-€44m) initial public offering (IPO) by US-based drug delivery specialist MonoSol Rx has fallen foul of the credit crunch and fears about a slowing US economy. ...
Abuse-resistant oxycodone primed for clinical trials
30-Mar-2008 - IntelliPharmaCeutics is ready to move into full-scale clinical trials with a once-daily oral formulation of oxycodone based on the company's ReXista abuse- and alcohol-resistant technology.
California gives industry a two-year reprieve on ePedigree
30-Mar-2008 - Pharmaceutical manufacturers, distributors and retailers alike have welcomed a unanimous vote by the California State Board of Pharmacy to delay for another two years the implementation of electronic pedigree requirements...
27-Mar-2008
SemBioSys prepares to file novel insulin product with FDA
27-Mar-2008 - Canada's SemBioSys Genetics has begun final pre-clinical studies of its novel plant-produced insulin product in preparation for its submission to US regulatory authorities.
FDA deadlines compromise drug safety
27-Mar-2008 - New research has shown that the FDA's strict 10-month deadline for a drug's approval following submission may compromise drug safety and lead to insufficient data for precise drug administration.
New comprehensive database details all known bacteria in human mouth
27-Mar-2008 - A new, freely available database has been launched that provides comprehensive information about the 600 known bacteria living in the human mouth. Many of these bacteria also cause infections in...
Biotage introduces automation solution for microwave chemistry
27-Mar-2008 - Biotage has used the American Chemical Society (ACS) Spring 2008 meeting to introduce its new batch microwave synthesiser that allows the full automation of batch sequencing resulting in time savings...
No joy for MHRA but tighter rules for pharma following Seroxat probe
27-Mar-2008 - The pharmaceutical industry in the UK faces tougher legislation on the disclosure of adverse events in clinical trials following the MHRA's thwarted attempt to prosecute GlaxoSmithKline for allegedly withholding information...
EU's ageing science workforce could damage future innovations
27-Mar-2008 - The ageing population of the European Union (EU) could result in a stagnation in technological innovation, according to a new report. As science and technology professionals get older and less...
Record R&D investment in US
27-Mar-2008 - Research and development investment by America's pharmaceutical and biotechnology research companies reached a record $58.8bn last year, a rise of $3bn since 2006.
26-Mar-2008
Health Canada issues draft rules for subsequent entry biologics
26-Mar-2008 - Drug regulator Health Canada has published its draft guidelines for pharmaceutical firms seeking to gain approval for biosimilars or "subsequent entry biologics."
Researchers achieve scalable fullerene production and separation
26-Mar-2008 - They showed promise in everything from drug delivery to the development of superconductive compounds, but so far fullerenes have been difficult to produce and purify in sufficiently large quantities for...
Genomic research automation is goal for Febits analyser
26-Mar-2008 - German based Genomics specialists Febit aim to fully automate genomics research with the introduction of its analyser at Analytica 2008, which enables fully automated processing of microarrays on Geniom biochips.
DSMB backs Medidur
26-Mar-2008 - Medidur has been deemed safe by the Data Safety Monitoring Board (DSMB) for continuation of Phase III clinical trials with no amendments to the protocol.
Metagenomics indicates changes in microbial communities
26-Mar-2008 - A new bioinformatics technique, developed by researchers at the US Argonne National Laboratory, is allowing researchers to rapidly screen the genetic sequences present microbial communities.
Rhodia starts to unravel Organics business
26-Mar-2008 - French group Rhodia has put its gradual retreat from a flagging fine chemicals business on a more formal footing by announcing the break-up of Rhodia Organics.
New US biosimilars bill a disappointing distraction, says GPhA
26-Mar-2008 - The generic pharmaceutical industry has given short shrift to the latest congressional attempt to construct a viable approval pathway for biosimilars in the US.
Redpoint Bio receives taste sensor patent
26-Mar-2008 - Redpoint Bio has been issued with a patent for an assay technology which tests whether a compound enhances or inhibits the bitter or sweet taste of different ingredients, allowing the...
Clinical contract news in brief
26-Mar-2008 - Outsourcing-Pharma.com compiles the news that has featured in the clinical contract community of late, involving PRA International and Premier Research.
UK pharma industry set to lose business offshore
26-Mar-2008 - The pharmaceutical industry has lost confidence in the UK as a place to do business to an "alarming degree" and the situation is only set to deteriorate, reveals new research....
25-Mar-2008
Product News in Brief
25-Mar-2008 - Varian, Invitrogen, BMG Labtech and Hosokawa Micron have all recently announced new product launches, detailing a selection of tools and equipment to aid the scientist working in the laboratory environment.
ISPE links with university for hands-on biopharma training
25-Mar-2008 - The International Society for Pharmaceutical Engineering (ISPE) is offering a "unique training experience" for pharmaceutical professionals through a partnership with North Carolina State University in the US.
Customer recalls product using Cambrex API
25-Mar-2008 - Cambrex Corp, the US-based manufacturer of small-molecule active pharmaceutical ingredients (APIs) and advanced intermediates for the drug industry, has announced that one of its customers is recalling a product for...
Heparin recall widens in US
25-Mar-2008 - The heparin recall has widened after a lot of heparin sodium USP active pharmaceutical ingredient (API) produced by Scientific Protein Laboratories (SPL) was found to contain a heparin-like contaminant.
Mass Spec Delight
25-Mar-2008 - MassWorks sCLIPS (self Calibrated Line-Shape Isotope Profile Search), a new software tool for the mass spectrometrist to allow molecular formula determination from accurate mass determinations, was launched at Pittcon by...
Researchers explain particle motion in microchannels
25-Mar-2008 - Engineers from the U.S think they have discovered a new technique that allows them to control the motion of fluid particles as they pass through the tiny channels that characterise...
Toyama acquisition shows Fujifilm's pharma ambitions
25-Mar-2008 - Japan's Fujifilm Holdings has taken a definitive sidestep into pharmaceuticals after completing a tender offer that gives the camera, photography and information solutions specialist a share stake representing 67.42 per...
Expression Analysis buys novel DNA sequencing technology
25-Mar-2008 - Genomic services firm Expression Analysis has purchased the first-ever commercially-available technology to allow the sequencing of a single molecule of DNA, without amplification.
20-Mar-2008
FDA identifies heparin contaminant; confirms China link
20-Mar-2008 - The US Food and Drug Administration (FDA) has now identified the contaminant found in samples of Baxter's recalled heparin and confirmed that it is indeed linked to a Chinese manufacturing...
Biotech driving lab reagent market to 2010
20-Mar-2008 - The worldwide laboratory chemical reagents market is expected to reach $13.7bn by 2010, buoyed by the biotechnology sector, neuroscience research and proteomics.
Generic drag cant hold back Siegfried's API momentum
20-Mar-2008 - Switzerland's Siegfried Holding says that a significant jump in 2007 net profit, up 54 per cent to CHF 49.7m ($50m), vindicates its decision to refocus on the active pharmaceutical ingredients...
Alkermes takes AIR Insulin blow with redundancies, facility closure
20-Mar-2008 - US-based drug delivery specialist Alkermes is cutting its losses following Eli Lilly's decision to scrap the companies' joint development programme for inhaled insulin.
Scientists wake up ancient Sleeping Beauty jumping gene
20-Mar-2008 - Scientists have successfully created the first artificial transposon - a piece of DNA which randomly "jump" around the genome, cutting and pasting itself throughout the strands of DNA.
Nycomed takes bulk of API production offshore
20-Mar-2008 - Mid-sized European pharma company Nycomed has struck a deal to offshore the vast majority of its raw materials sourcing to India, in a move which could affect around 200 jobs.
Inhaled TB vaccine shows promising results
20-Mar-2008 - Animal studies reveal that we may be on the road to creating the first inhaled vaccine for tuberculosis, with results showing the vaccine to be at least as effective as...
19-Mar-2008
Commission sets out its stall on anti-counterfeiting measures
19-Mar-2008 - Batch pedigrees, obligatory product seals, mass serialisation, mandatory audits and tighter requirements for the manufacture, import, export and transportation of medicinal products are among the legislative steps being considered by...
US team claims a first in nanovalves for drug delivery
19-Mar-2008 - A team of nanotechnologists and chemists based in the USA has created a novel nanovalve that could be used to deliver medications according to the pH environment in the body.
'Lego' construction kit eases lab automation
19-Mar-2008 - A new modular approach to automating laboratory techniques could ease the process of scaling small-scale manual methods to high-volume commercial production.
Revised glycerin monograph announced to combat contamination
19-Mar-2008 - A revised glycerin monograph has been announced at the US Pharmacopeial (USP) Convention which it is hoped will further decrease the likelihood of health hazards associated with diethylene glycol-contaminated glycerin.
Hydrogel success calls for jolly good knees-up
19-Mar-2008 - US scientists believe they may have developed an unusual material that has similar physical properties of gelatine, remaining intact even when deformed over 1,000 per cent. Its make up gives...
EUR 15m project to uncover secrets of membrane proteins
19-Mar-2008 - They play an important role in diseases such as diabetes and epilepsy but until now the structure and activity of proteins found in cell membranes have been little understood compared...
18-Mar-2008
Laboratory product news in brief
18-Mar-2008 - LabTechnologist.com presents a round-up of new products that have been introduced to the laboratory equipment market of late, including items from Applied Biosystems, Olympus, Gentronix and Radleys.
Applied Bio sequences a human genome for $60,000
18-Mar-2008 - Applied Biosystems has sequenced a human genome for just $60,000 in a project that significantly undercuts the $100,000 milestone achieved by the industry and setting the scene for a price...
TMH autoinjector to reach US after FDA go-ahead
18-Mar-2008 - A disposable autoinjector that incorporates pre-filled syringes to allow injections to be safely undertaken by patients or non-clinicians has received FDA approval allowing its creators access to the lucrative US...
FDA makes progress in plans for China presence
18-Mar-2008 - The US Food and Drug Administration (FDA) has alerted the media that it has taken a significant step forward in its plans to establish a presence on the ground in...
Omnitrope Pen 5 ups the convenience factor
18-Mar-2008 - A new, more patient-friendly presentation of the growth hormone treatment Omnitrope (rDNA somatropin) has been launched in the US by Sandoz, the generics division of Swiss-based Novartis.
Peptide Technologies extends synthesis range with new Tribute
18-Mar-2008 - Peptide Technologies showcased their latest rapid automated peptide synthesis equipment at Pittcon 2008, including a new product, the benchtop Tribute instrument.
Crucell, DSM hit 15g/L milestone with PER.C6 technology
18-Mar-2008 - Dutch biotech Crucell and its US partner DSM Biologics have achieved a record yield of 15 grams per litre with their PER.C6 cell line technology for the production of monoclonal...
Synthetic biology research centre established in NL
18-Mar-2008 - The University if Groningen in the Netherlands has established a new research centre dedicated to the growing discipline of synthetic biology and its application to the production of biologic medicines.
17-Mar-2008
Sartorius mergers cap off 'a successful and intense 2007'
17-Mar-2008 - A successful and strategically important year,' is how Sartorius CEO Joachim Kreuzburg described 2007, a year highlighted by merger of its biotechnology division with Stedim to boost its presence in...
GMP an unnecessary burden for excipients, review concludes
17-Mar-2008 - The costs of introducing any formal good manufacturing practice (GMP) requirements for potentially high-risk pharmaceutical excipients in the European Union would far exceed the likely benefits, concludes an impact assessment...
Strong growth seen in US for barrier plastic packaging
17-Mar-2008 - Pharmaceutical applications in the US market for barrier plastic packaging should continue to generate strong growth over the next five years, as the wider healthcare packaging market carries on expanding...
Pharmaceutics International branching out
17-Mar-2008 - Pharmaceutics International has been branching out of late, with an expansion, an acquisition and a new partnership.
Pharma: why the wandering eye towards emerging markets?
17-Mar-2008 - Outsourcing-Pharma explores the driving force behind the pharma industry's escalating wandering eye towards emerging markets.
13-Mar-2008
NanoDrop makes low volume analysis a cinch
13-Mar-2008 - NanoDrop, now part of Thermo Fisher Scientific, made a big impact at Pittcon 2008 with its range of micro-volume UV-vis and fluorescence spectroscopy instruments.
FT-IR comes of age at Thermo
13-Mar-2008 - Thermo Fisher released a comprehensive range of new laboratory spectrometers at Pittcon 2008, with the firm's emphasis on FT-IR very much in evidence.
Biofuel analyser debuts at Pittcon
13-Mar-2008 - Aspectrics introduced a new biodiesel analyser at Pittcon 2008 based upon their Encoded Photometric Near Infra Red (EP-NIR) technology, which uses a specially designed 128 channel encoder disc.
12-Mar-2008
Thermo Fisher claims breakthrough with gene-silencing agent
12-Mar-2008 - Research into the use of RNA interference (RNAi) to "silence" gene activity has taken another step forwards, saysThermo Fisher Scientific which has launched an agent that accelerates the processes in...
Merck KGaA still has an eye to buy in pharma
12-Mar-2008 - Germany's Merck KGaA is still on the lookout for acquisitions or in-licensing deals to fill out its pharmaceutical business following the purchase and integration of Swiss biotech Serono.
Pharmaceutical traces in water 'highly unlikely to harm', says industry
12-Mar-2008 - Politicians in the US have gone on the offensive while regulators and industry groups have circled their wagons over a five-month investigation by the Associated Press that has rung alarm...
Genetic switches discovery could mean lights out on cancer
12-Mar-2008 - European researchers think they may have found a series of DNA switches that control which genes are switched on and when, giving rise to a new research direction that may...
Device gives scientists the power to control cell reproduction
12-Mar-2008 - A unique device that allows control gene activity during cell multiplication has been produced by US researchers, who believe this technology will allow them to construct pedigrees, comparing gene activity...
Neose to advance PEG products in 2008
12-Mar-2008 - PEGylation specialist Neose Technologies says that it has now refocused its R&D focus since the demise of its lead drug candidate last year, and will concentrate on two drugs for...
Crystallisation method yields new protein structure clues
12-Mar-2008 - A new method for crystallising proteins and making them easier to experiment on has been devised by scientists, who believe this technique will uncover the innermost structure of more complex...
11-Mar-2008
China-made heparin scare spreads beyond US
11-Mar-2008 - The made-in-China heparin scare has now spread beyond the US, with Germany and Japan both recalling the drug.
Contract manufacturing news in brief
11-Mar-2008 - Cobra Biomanufacturing, Crucell, Vetter, Arch Pharmalabs and Lonza have all recently announced new contract manufacturing news.
Patheon's Q1 profits drop as it continues to address Puerto Rico
11-Mar-2008 - Patheon's first quarter results have continued to be impacted by its underperforming Puerto Rico operations, although restructuring plans to remedy the situation are in full swing.
Roche deal tests drug cardiotoxicity on unique lab platform
11-Mar-2008 - Roche has entered into an agreement to provide drug compounds for cardiotoxicity testing using a cell-based platform that could play a major role in the preclinical safety evaluation of drugs...
Mammalian-cell biosensor accelerates pathogen detection
11-Mar-2008 - A new biosensor made from mouse white blood cells could provide a quick and easy test for microbes and toxins in food. The sensor can return results in just a...
Silicon tuning fork provides early detection of prion diseases
11-Mar-2008 - A silicon tuning fork that changes pitch in the presence of deadly prions could provide an early detection of diseases such as bovine spongiform encephalopathy (BSE) and its human counterpart...
Nektar optimistic despite Exubera fallout
11-Mar-2008 - The CEO of Californian company Nektar Therapeutics says that 2007 has been key in transforming the company into a fully integrated drug development organisation, despite the setback with Pfizer's inhaled...
Eurand's formulations stack up at the FDA
11-Mar-2008 - Drug delivery specialist Eurand could see a marked increase in revenue flow this year, both from co-development products incorporating the company's formulation technologies and a proprietary treatment addressing the estimated...
Scientists challenge amniotic stem cell research
11-Mar-2008 - It had been touted as providing a less controversial alternative to embryonic stem cells, but Italian researchers have thrown into question the validity of research claiming to demonstrate the use...
Lilly declines to inhale with AIR Insulin programme
11-Mar-2008 - The prospects for a viable market in inhaled insulin therapies were looking markedly thinner this week after Eli Lilly pulled the plug on its joint development programme with drug delivery...
10-Mar-2008
Hovione makes latest investment in China
10-Mar-2008 - Portugal's Hovione has become the latest in a spate of pharma industry players to invest further in China.
ACIP recommendations are a seasonal bounty for FluMist
10-Mar-2008 - MedImmune is taking advantage of a new US recommendation on the immunisation of school children to almost triple production of its intranasal influenza vaccine, FluMist, for the coming 'flu season.
US pharma RFID market set for 60 per cent growth
10-Mar-2008 - The promise of genuine returns on investment, facilitated by plummeting hardware costs, will fuel a dramatic growth surge in the US market for radio frequency identification (RFID) technology in pharmaceutical...
Continuous reactor promises production 'revolution'
10-Mar-2008 - Alfa Laval has introduced new plate technology for the continuous production of pharmaceuticals, fine chemicals and speciality chemicals that has "the potential to start something of a revolution in the...
07-Mar-2008
Heparin contamination emerges after FDA China investigation
07-Mar-2008 - A US Food and Drug Administration (FDA) investigation into the recent Baxter heparin scare has uncovered a contaminant in the product that was sourcing the active pharmaceutical ingredient (API) from...
06-Mar-2008
New products for the laboratory scientist
06-Mar-2008 - LabTechnologist.com brings you a round up of the latest product news and releases. This week Agilent, Biotage and Ruskinn Technology head the queue with products designed for laboratory research and...
Direct particle analysis at the nano level
06-Mar-2008 - A joint development partnership between Malvern Instruments and imaging specialist FEI has produced what the companies claim is the first ever tool for determining the size and shape of sub-micron...
Portable FTIR a hit at Pittcon
06-Mar-2008 - Fourier transform infrared spectroscopy (FTIR) has hit the headlines at Pittcon 2008 with the release of ground breaking instruments from a number of companies.
Fumehood maker shows rivals how to go green
06-Mar-2008 - A new user and environmentally-friendly fume hood claimed to cut emissions as well as operating and energy costs has been launched at Pittcon 2008.
'Nested' nanoparticles increase efficiency of drug delivery
06-Mar-2008 - A "matryoshka doll" filled with drugs could be the missing link that finally allows nanomedicine to fulfil its potential.
Flamel suffers greater losses in 2007
06-Mar-2008 - Flamel Technologies has yet again experienced a net loss of $37.2m for 2007, following a string of bad fortune in 2005 and 2006, but believes it may be about to turn the corner.
Pfizer eyeing emerging markets in growth plan
06-Mar-2008 - Pfizer has outlined a number of strategies for growing its fledgling pipeline and lowering its cost base and is planning to increase globalisation and accelerate growth in emerging markets as...
05-Mar-2008
Donut-shaped organic molecule mops up chemical waste
05-Mar-2008 - Dissolved charged particles frequently form the waste product of both industrial and biological processes, but while it has been easy to remove positive ions (cations) without disturbing the surrounding solution,...
Fighting bacteria produce new antibiotic
05-Mar-2008 - Scientists have provoked a soil-dwelling bacteria into producing a potent antibiotic by pitting it against another bacteria, despite the fact that previously it had never been known to produce such...
Ferro's pharma business falters in Q4, 2007
05-Mar-2008 - There were distinct signs of faltering progress in the pharmaceutical business of US-based performance materials supplier Ferro Corporation during the fourth quarter and year ended 31 December 2007.
MicroDose and Merck agree $32m DPI deal
05-Mar-2008 - Merck & Co has signed a $32m deal to evaluate MicroDose Technologies' dry powder inhalation technology in the delivery of some of its respiratory product lines.
04-Mar-2008
Rapid DNA testing kit could help in sex crimes
04-Mar-2008 - Applied Biosystems has developed a new chemistry reagent kit for DNA analysis by forensic laboratories of material recovered in sexual assault cases. In these cases speed and accuracy are the...
DiaMed helps Bio-Rad to strong growth in 07
04-Mar-2008 - Bio-Rad Laboratories has reported strong growth in the last quarter of 2007, with a 34 per cent increase in revenue compared to the last quarter of 2006. These results have...
Applera shake up as company does the splits
04-Mar-2008 - Applera has announced its intentions to separate its Celera Group from the Applera Corporation, forming a separate, publicly-traded company, subject to approval from the US Securities and Exchange Commission and...
FDA 'concerned' after inspection of China heparin plant
04-Mar-2008 - The US Food and Drug Administration (FDA) has alerted the media to the preliminary findings of its inspection of the Chinese facility that supplied the active pharmaceutical ingredient (API) for...
Supply chain globalisation weighs heavily on FDA
04-Mar-2008 - The globalisation of the supply chain increasingly challenges the US Food and Drug Administration's ability to ensure the quality of pharmaceuticals on the US market, acknowledges the acting director of...
ACT licence beefs up Pharmings transgenic cattle portfolio
04-Mar-2008 - Dutch biotech Pharming has solidified its patent position in the use of transgenic cattle to produce protein therapeutics through a licence agreement with Advanced Cell Technology (ACT), a US company...
Biodegradable 'cells' boost immune system
04-Mar-2008 - A "biodegradable yarn ball" filled with stimulatory proteins that boost the immune system could constitute the next generation of adaptive immunotherapy for cancer.
03-Mar-2008
BASF hikes prices on intermediates, hydrosulfites
03-Mar-2008 - German chemicals giant BASF has announced its latest brace of price rises, this time for two forms of carboxylic acid and for bleaching and reducing agents.
Bruker on R&D high as Q4 exceeds expectations
03-Mar-2008 - Life sciences systems maker Bruker Corp reported stronger-than-expected fourth-quarter earnings and revenue results on the back of the company's recent $1.1bn acquisition of affiliated firm Bruker BioSpin.
Teva sprints ahead of the API field
03-Mar-2008 - With active pharmaceutical ingredient sales of $1,460m (€960.8m) in 2007 and a portfolio of more than 250 compounds, Teva Pharmaceutical Industries is by a long stretch the dominant supplier in...
Computer modelling improves lab data quality
03-Mar-2008 - A new study shows how to get high quality immune-system protein information at the fraction of the current cost. Researchers have introduced a statistical model, which makes use of existing...
NIH to lighten up heavy peer review process
03-Mar-2008 - Researchers applying to the US National Institutes of Health (NIH) for research grants could find the complicated peer-review process easier to navigate in the future under new proposals designed to...
GSK's UK plant to lose out to outsourcing
03-Mar-2008 - A UK chemicals plant has become the latest casualty of GlaxoSmithKline's (GSK's) pledge to make the business leaner with the help of outsourcing and offshoring.
Pittcon 2008 opens its doors
03-Mar-2008 - Pittcon 2008 has kicked off and as usual exhibitors have kept their newest and most innovative technology for release at the show. LabTechnologist.com's Huw Kidwell is on the ground in...
Lillys Zyprexa LAI trips up over sedation effects
03-Mar-2008 - A long-acting injectable formulation of Eli Lilly's blockbuster schizophrenia treatment Zyprexa (olanzapine), with the potential to improve patient adherence and take some of the sting out of generic competition three...
| « Previous month | Next month » |
Most Popular News
Key Industry Events
Products
On demand Supplier Webinars
Discover innovative single-use mixer for efficient mixing of low shear and particulate sensitive solutions in cGMP environment
ATMI Life Science
ATMI Life Science
